Cargando…

Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinson’s Disease

Quercetin, a natural antioxidant, exhibits potential neuroprotective effects by efficiently downregulating α-synuclein protein aggregation and associated neurological hallmarks, responsible for the progression of Parkinson’s Disease.

Detalles Bibliográficos
Autores principales:	Das, Sabya Sachi, Jha, Niraj Kumar, Jha, Saurabh Kumar, Verma, Priya Ranjan Prasad, Ashraf, Ghulam Md, Singh, Sandeep Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2023
Materias:	Medicine, Neurology, Pharmacology, Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472805/ https://www.ncbi.nlm.nih.gov/pubmed/36545726 http://dx.doi.org/10.2174/1570159X21666221221092250

Ejemplares similares

Food-Grade Quercetin-Loaded Nanoemulsion Ameliorates Effects Associated with Parkinson’s Disease and Cancer: Studies Employing a Transgenic C. elegans Model and Human Cancer Cell Lines
por: Das, Sabya Sachi, et al.
Publicado: (2022)

Liquid Chromatography–Electrospray Ionization Tandem Mass Spectrometry Estimation of Quercetin-Loaded Nanoemulsion in Rabbit Plasma: In Vivo–In Silico Pharmacokinetic Analysis Using GastroPlus
por: Das, Sabya Sachi, et al.
Publicado: (2023)

Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer’s and Parkinson’s Diseases
por: Javed, Hayate, et al.
Publicado: (2023)

Characterization and Exploration of Placket–Burman-Designed Porous Calcium Carbonate (Vaterite) Microparticles
por: Singh, Avi, et al.
Publicado: (2023)

Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease
por: Jana, Ankit, et al.
Publicado: (2022)

Cannabidiol-Loaded Nanocarriers and Their Therapeutic Applications
por: Assadpour, Elham, et al.
Publicado: (2023)

Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy
por: Ganguly, Upasana, et al.
Publicado: (2018)

Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection
por: Shandilya, Shruti, et al.
Publicado: (2021)

p38 MAPK and PI3K/AKT Signalling Cascades inParkinson’s Disease
por: Jha, Saurabh Kumar, et al.
Publicado: (2015)

Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson’s Disease Models
por: Verma, Dinesh Kumar, et al.
Publicado: (2021)

Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson’s Disease
por: Palmas, Maria Francesca, et al.
Publicado: (2022)

Biopolymer-Capped Pyrazinamide-Loaded Colloidosomes: In Vitro Characterization and Bioavailability Studies
por: Singh, Avi, et al.
Publicado: (2023)

Transmission of alpha-synuclein in Parkinson’s disease
por: Lee, Virginia M-Y
Publicado: (2013)

Alpha-synuclein spreading in Parkinson’s disease
por: Recasens, Ariadna, et al.
Publicado: (2014)

Alpha-Synuclein Aggregation in Parkinson's Disease
por: Srinivasan, E., et al.
Publicado: (2021)

Neuroprotective Potential of Limonene and Limonene Containing Natural Products
por: Eddin, Lujain Bader, et al.
Publicado: (2021)

Alpha-synuclein stimulation of astrocytes: Potential role for neuroinflammation and neuroprotection
por: Lee, He-Jin, et al.
Publicado: (2010)

Neuroprotective effect of quercetin and Zingiber officinale on sodium arsenate‐induced neurotoxicity in rats
por: Yousuf, Rasia, et al.
Publicado: (2023)

Molecular Mechanism and Role of Japanese Encephalitis Virus Infection in Central Nervous System-Mediated Diseases
por: Yadav, Pardeep, et al.
Publicado: (2022)

Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2
por: Mathur, Aanchal, et al.
Publicado: (2021)

Comparative study of anti-angiogenic activities of luteolin, lectin and lupeol biomolecules
por: Ambasta, Rashmi K., et al.
Publicado: (2015)

Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
por: Gómez-Benito, Mónica, et al.
Publicado: (2020)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
por: Fan, Tian-Sin, et al.
Publicado: (2021)

Pharmacological and Molecular Insight on the Cardioprotective Role of Apigenin
por: Thomas, Shilu Deepa, et al.
Publicado: (2023)

Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough
por: Ganguly, Upasana, et al.
Publicado: (2021)

Evaluation of Antidiabetic, Antioxidant and Anti-Hyperlipidemic Effects of Solanum indicum Fruit Extract in Streptozotocin-Induced Diabetic Rats
por: Gadewar, Manoj M., et al.
Publicado: (2023)

Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects
por: Pritam, Pingal, et al.
Publicado: (2022)

Rationale for Therapeutic Silencing of Alpha-Synuclein in Parkinson’s Disease
por: Maraganore, Demetrius M.
Publicado: (2011)

Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
por: Xu, Shengli, et al.
Publicado: (2015)

Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
por: George, Sonia, et al.
Publicado: (2015)

New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
por: Zhang, Guoxin, et al.
Publicado: (2018)

The Identification of Alpha-Synuclein as the First Parkinson Disease Gene
por: Nussbaum, Robert L.
Publicado: (2017)

Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease
por: Fitzgerald, Emily, et al.
Publicado: (2019)

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
por: Fields, Carroll Rutherford, et al.
Publicado: (2019)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
por: Li, Puyu, et al.
Publicado: (2021)

The Neuroprotective Role of Protein Quality Control in Halting the Development of Alpha-Synuclein Pathology
por: Manecka, Destiny-Love, et al.
Publicado: (2017)

CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics
por: Bhardwaj, Shanu, et al.
Publicado: (2021)

Oxidative Stress in Cancer Cell Metabolism
por: Arfin, Saniya, et al.
Publicado: (2021)

Temperature-Dependent Structural Changes of Parkinson's Alpha-Synuclein Reveal the Role of Pre-Existing Oligomers in Alpha-Synuclein Fibrillization
por: Ariesandi, Winny, et al.
Publicado: (2013)

Evaluation of neuroprotective effect of quercetin with donepezil in scopolamine-induced amnesia in rats
por: Pattanashetti, Laxmi Adiveppa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n4m197slg3b1tvdeg03i1j0rv0